Novartis Accused Of 'Ducking And Diving' MS Patent Fight
Lawyers for Teva have accused Novartis AG of "ducking and diving" to avoid scrutiny of its patent application for a multiple sclerosis treatment, as they fought at trial on Monday to...To view the full article, register now.
Already a subscriber? Click here to view full article